Lisocabtagene maraleucel (liso-cel), a chimeric antigen receptor (CAR) T-cell therapy, is cost-effective for second-line diffuse large B-cell lymphoma (DLBCL) therapy, according to a study published online Dec. 28 in Blood Advances.
New antibiotic slays deadly superbug in early trial
Researchers report that a new type of antibiotic has proved its mettle against a deadly superbug.
Research shows more lives can be saved if ambulance staff receive AI support
Assessing how seriously injured a person is, involves weighing up lots of different parameters fast. If health care professionals could get support making fast-paced, life-critical decisions from an AI tool, more lives could be saved. This has been shown by research from Chalmers University of Technology in Sweden, along with the University of Gothenburg and the University of Borås.
New technique could improve liver fibrosis treatment
Chronic liver disease, a growing threat to global health, often progresses silently in its early stages. Detecting its precursor, steatotic liver disease (SLD), and advanced liver fibrosis before complications arise is crucial to prevent devastating outcomes. The newly developed Chronic Liver Disease (CLivD) score offers a promising non-invasive approach to this challenge.
AI-driven study redefines right heart health assessment with novel predictive model
In a milestone study, researchers from the Icahn School of Medicine at Mount Sinai have harnessed the power of artificial intelligence (AI) to enhance the assessment of the heart’s right ventricle, which sends blood to the lungs.
Study finds Paxlovid treatment does not reduce risk of long COVID
A team of researchers from UC San Francisco has found that Paxlovid (Nirmatrelvir-ritonavir) did not reduce the risk of developing long COVID for vaccinated, non-hospitalized individuals during their first COVID-19 infection. They also found a higher proportion of individuals with acute symptoms rebound and test-positivity than previously reported.
Transgender, gender-diverse individuals report acne-related stigma
Transgender and gender-diverse individuals report experiencing acne-related stigma, according to a study published online Jan. 3 in JAMA Dermatology.
Study shows liquefied petroleum gas does not reduce stunted growth in infants
An intervention that replaces biomass fuel (e.g., wood, dung, or agricultural crop waste) with liquefied petroleum gas (LPG) for cooking does not reduce the risk for stunted growth in infants, according to a study published in the Jan. 4 issue of the New England Journal of Medicine.
FDA looking into new risks with popular weight-loss drugs
The U.S. Food and Drug Administration is investigating reports of additional dangers linked to several wildly popular weight-loss drugs.
Liquefied petroleum gas does not affect severe pneumonia risk in infants, finds study
An intervention that replaces biomass fuel (e.g., wood, dung, or agricultural crop waste) with liquefied petroleum gas (LPG) for cooking does not affect the incidence of severe pneumonia among infants, according to a study published in the Jan. 4 issue of the New England Journal of Medicine.